Timber Pharmaceuticals Inc (NYSE American:TMBR)

1.09
Delayed Data
As of 3:59pm ET
 -0.18 / -14.17%
Today’s Change
0.67
Today|||52-Week Range
10.44
+46.70%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$58.3M

Company Description

Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, tuberous sclerosis complex, and localized scleroderma. The company was founded in 2019 and is headquartered in Basking Ridge, NJ.

Contact Information

Timber Pharmaceuticals, Inc.
110 Allen Road
Basking Ridge New Jersey 07920
P:(914) 205-3481
Investor Relations:

Employees

Shareholders

Individual stakeholders30.03%
Other institutional2.71%
Mutual fund holders0.66%

Top Executives

John KoconisChairman & Chief Executive Officer
Zachary RomeCOO, Secretary, Director & Executive VP
Joseph LuccheseChief Financial Officer & Executive Vice President
Alan MendelsohnChief Medical Officer & Executive Vice President